期刊
DIABETES RESEARCH AND CLINICAL PRACTICE
卷 81, 期 -, 页码 S23-S30出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2008.06.010
关键词
initiation; intensification; biphasic insulin aspart 30; type 2 diabetes
资金
- Novo Nordisk International Operations
This paper aims to underscore the importance of insulin intensification, while highlighting the clinical utility of modem premixes through intensification lessons, by utilising data from key clinical trials, and from the recently published large observational PRESENT Study. insulin intensification is any change made to an initial insulin regimen to improve glycaemic control. Yet, despite established glycaemic targets, current HbA1c levels in insulin-treated patients suggest that 'real-world' insulin regimens are not optimally intensified. When treatment is intensified as needed, patients are more likely to achieve and maintain glycaemic targets, as evidenced by treat-to-target trials utilising forced titration algorithms. Both clinical and observational studies suggest that modem premixes, such as biphasic insulin aspart 30, represent an effective and well-tolerated option when intensifying a number of existing insulin regimens that no longer maintain optimal glycaemic control. However, physician and patient concerns regarding initiation and intensification of insulin therapy can create barriers to effective patient care, and it is essential that such barriers be resolved. Although it is important to encourage patients to initiate insulin therapy when needed, it is equally important that insulin regimens benefit from ongoing intensification in order to maintain glycaemic control as type 2 diabetes follows its typically progressive course. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据